News Release

the 5th China Interstitial Lung Disease Conference

In the 5th China Interstitial Lung Disease Conference held in Changsha, Hunan Province, from July 29 to July 30, 2016, pirfenidone was listed as the recommended treatment for idiopathic pulmonary fibrosis in the doctors' consensus. Beijing Continent Pharmaceutical Co., Ltd. sponsored an Excellent Reports and Selection of Pirfenidone Clinical Case Study, a Patients and China/Germany Key Interstitial Lung Disease Doctors Communication Meeting, and a banquet entitled The Night of Etuary®. Thomas Easting, representative director of GNI Group Ltd., greeted the doctors and handed out award for the winners of the Excellent Research Paper Competition.

Please refer to our Facebook page for the related pictures.
https://www.facebook.com/GNITokyo/